Smart Pills Patient Monitoring Market Analysis

  • Report ID: 3864
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Smart Pills Patient Monitoring Market Analysis

Application (Capsule Endoscopy, Patient Monitoring, and Drug Delivery)

The global smart pills patient monitoring market is segmented and analyzed for demand and supply by application into capsule endoscopy, patient monitoring, and drug delivery. Out of these three types of segments, the capsule endoscopy segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the rising traction for non-invasive procedures among people, followed by the radical boost in cases of gastrointestinal disorders such as irritable bowel syndrome, peptic ulcers, and so on throughout the world. For instance, around 5 million people worldwide suffer from peptic ulcer disease each year, with a lifelong prevalence in the general population of nearly 6–12%. Moreover, surging concern in people regarding digestive health is another significant factor that is projected to hike the segment growth over the forecast period.

Target Area (Esophagus, Stomach, Small Intestine, and Large Intestine)

The global smart pills patient monitoring market is also segmented and analyzed for demand and supply by target area into esophagus, stomach, small intestine, and large intestine. Amongst these four segments, the small intestine segment is expected to garner a significant share. The growth of the segment can be attributed to the dynamically growing ratio of small intestine diseases such as celiac disease, small bowel tumors, Crohn’s disease, and so on. For instance, according to a research study in the year 2020, the worldwide frequency of celiac disease has surged by around 7.8% each year on average over the last several years, with ladies and children being the most affected. Based on serologic tests, it has been estimated that nearly 1.6% of the world's population has celiac disease, with prevalence rates of around 0.3% in South America, 0.4% in Africa and North America, 0.6% in Asia, and 0.9% in Europe and Oceania. On the other hand, the stomach segment is projected to witness a notable CAGR during the forecast period. Smart pills aid in monitoring the passage of food through the digestive tract. Furthermore, ongoing research and development in the field of smart pill monitoring are some significant factors that are anticipated to expand the growth of the segment in the coming years.

Our in-depth analysis of the global market includes the following segments:

        By Target Area

  • Esophagus
  • Stomach
  • Small Intestine
  • Large Intestine

         By Application

  • Capsule Endoscopy
  • Patient Monitoring
  • Drug Delivery

          By Disease Indication

  • Small Bowel Tumors
  • Celiac Disease
  • Inherited Polyposis Syndromes
  • Neurological Disorders
  • Crohn’s Disease
  • Occult GI Bleeding
  • Others

            By End-User

  • Hospitals
  • Specialty Clinics
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3864
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of smart pills patient monitoring is evaluated at USD 6.63 Billion.

The smart pills patient monitoring market size was over USD 5.8 Billion in 2023 and is expected to exceed USD 39.46 Billion by the end of 2036, witnessing over 15.9% CAGR during the forecast period i.e., between 2024-2036. Increasing ratio of various types of chronic disorders, rising prevalence of gastrointestinal reflux disease (GERD), and worldwide increase in neurological disorders are the major factors driving the market growth.

North America is likely to dominate majority industry share by 2036, attributed to higher frequency of colorectal cancer amongst people, driven by rise in sedentary lifestyles, and rapidly surging ratio of geriatric populace in the region.

Medtronic plc, AbbVie Inc., Novartis AG, CapsoVision, Inc., Medimetrics, SA de CV, TauRx Pharmaceuticals Ltd, Otsuka Pharmaceutical Co. Ltd., FUJIFILM Holdings Corporation,
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample